ACQUISITIONS AND INVESTMENTS (Details) - USD ($) $ in Millions |
Oct. 01, 2021 |
Feb. 10, 2021 |
Sep. 30, 2021 |
Mar. 31, 2021 |
Feb. 29, 2020 |
|---|---|---|---|---|---|
| Kount | |||||
| Business Acquisition [Line Items] | |||||
| Business acquisition, percentage of voting interests acquired | 100.00% | ||||
| Consideration transferred | $ 640 | ||||
| Hiretech and i2Verify | |||||
| Business Acquisition [Line Items] | |||||
| Business acquisition, percentage of voting interests acquired | 100.00% | ||||
| Health e(fx) and Teletrack | |||||
| Business Acquisition [Line Items] | |||||
| Business acquisition, percentage of voting interests acquired | 100.00% | ||||
| Appriss Insights | Subsequent Event | |||||
| Business Acquisition [Line Items] | |||||
| Business acquisition, percentage of voting interests acquired | 100.00% | ||||
| Consideration transferred | $ 1,825 | ||||
| India Joint Venture | |||||
| Business Acquisition [Line Items] | |||||
| Remaining ownership interest acquired (as a percent) | 40.60% |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Percentage of voting equity interests acquired at the acquisition date in the business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Percentage of voting equity interests acquired in a business combination achieved in stages, including equity interests in the acquiree held by the acquirer immediately before the acquisition date and acquired at the acquisition date. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|